Aberdeen Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Sell |
67,657
-40,472
| -37% | -$2.56M | 0.01% | 721 |
|
|
2025
Q1 | $5.73M | Buy |
108,129
+27,612
| +34% | +$1.46M | 0.01% | 667 |
|
|
2024
Q4 | $4.51M | Sell |
80,517
-32,287
| -29% | -$1.81M | 0.01% | 667 |
|
|
2024
Q3 | $5.91M | Hold |
112,804
| – | – | 0.01% | 623 |
|
|
2024
Q2 | $4.63M | Buy |
+112,804
| New | +$4.63M | 0.01% | 641 |
|
|
2019
Q2 | – | Sell |
-21,523
| Closed | -$590K | – | 936 |
|
|
2019
Q1 | $590K | Buy |
+21,523
| New | +$590K | ﹤0.01% | 847 |
|